IP Library Granted Patent US 8,633,326
Granted Patent B2
US 8,633,326 · App. 13/262,936 · Granted Jan 21, 2014

Method for preparing taxane derivatives

Inventors: Sang-Hyun Pyo (Daejeon, KR); Jin-Suk Cho (Daejeon, KR); Moon-Suk Kim (Daejeon, KR); Jai-Young Song (Daejeon, KR); Ho-Joon Choi (Daejeon, KR)
Assignee: Samyang Biopharmaceuticals Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,633,326
App. No.
13/262,936
Granted
Jan 21, 2014
Kind
B2
Abstract

Provided is a method for preparing a taxane derivative, comprising: carrying out condensation of a phenylisoserine derivatives having a protective group introduced thereto or a mixture of isomers thereof, as a side chain, with a baccatin III derivative or 10-deacetyl-baccatin III derivative to obtain a mixture of isomers; separating the isomers via chromatography; and carrying out a reversion of the stereochemical structure of a selectively separated isomer, which is suitable for producing a taxane derivative in a large scale with high yield.

Claims (37)

1. A method for preparing a taxane derivative represented by the following Chemical Formula (I), comprising the steps of:

1) carrying out condensation of a side chain with baccatin III represented by the following Chemical Formula III or 10-deacetyl-baccatin III derivative, having protective group(s) introduced to 7-hydroxyl group and/or 10-hydroxyl group, to obtain a mixture of a compound represented by the following Chemical Formula IVa with a compound represented by the following Chemical Formula IVb, wherein the side chain is selected from a (2R,3S)-phenylisoserine derivative, represented by the following Chemical Formula IIa and having protected groups introduced to 2-hydroxyl group and 3-amino group, and a mixture of the derivative with an isomer thereof, a (2S,3S)-phenylisoserine derivative, represented by the following Chemical Formula IIb;

2) deprotecting the side chain of the mixture (IVa, IVb) obtained from step 1) at C-2 position thereof to obtain a mixture of a compound represented by the following Chemical Formula Va with a compound represented by the following Chemical Formula Vb;

3) separating the mixture (Va, Vb) obtained from step 2) via chromatography to obtain each isomer compound;

4) carrying out a stereochemical reversion of one isomer compound (Vb) in the compounds obtained from step 3) into the other isomer compound (Va); and

5) deprotecting the isomer compound (Va) obtained from steps 3) and 4) at C-7 and/or C-10 position thereof to obtain a taxane derivative represented by the following Chemical Formula I:

wherein R 1 and R 2 are independently acetyl (Ac), tert-butyldimethylsilyl (TBS), triethylsilyl (TES), ethoxyethyl (EE), or 2,2,2-trichloroethoxycarbonyl (Troc);

R 3 is benzoyl (Bz) or tert-butoxycarbonyl (Boc);

R 4 is Ac, TBS, TES, EE, or Troc;

R 1 ′ is Ac or H; and

Ph is phenyl.

2. A method for preparing a taxane derivative represented by the following Chemical Formula (I), comprising the steps of:

1) carrying out condensation of a side chain with baccatin III represented by Chemical Formula III or 10-deacetyl-baccatin III derivative, having protective group(s) introduced to 7-hydroxyl group and/or 10-hydroxyl group, to obtain a mixture of a compound represented by Chemical Formula IVa with a compound represented by Chemical Formula IVb, wherein the side chain is selected from a (2R,3S)-phenylisoserine derivative, represented by Chemical Formula IIa and having protected groups introduced to 2-hydroxyl group and 3-amino group, and a mixture of the derivative with an isomer thereof, a (2S,3S)-phenylisoserine derivative, represented by Chemical Formula IIb;

2) separating the mixture (IVa, IVb) obtained from step 1) via chromatography to obtain each isomer compound;

3) deprotecting the side chain of each isomer compound obtained from step 2) at C-2 position thereof to obtain a compound represented by Chemical Formula Va and a compound represented by Chemical Formula Vb;

4) carrying out a stereochemical reversion of one isomer compound (Vb) in the compounds obtained from step 3) into the other isomer compound (Va); and

5) deprotecting the isomer compound (Va) obtained from steps 3) and 4) at C-7 and/or C-10 position thereof to obtain a taxane derivative represented by Chemical Formula I:

wherein R 1 , R 2 , R 3 , R 4 , R 1 ′ and Ph are the same as defined in claim 1 .

3. A method for preparing a taxane derivative represented by the following Chemical Formula (I), comprising the steps of:

1) carrying out condensation of a side chain with baccatin III represented by Chemical Formula III or 10-deacetyl-baccatin III derivative, having protective group(s) introduced to 7-hydroxyl group and/or 10-hydroxyl group, to obtain a mixture of a compound represented by Chemical Formula IVa with a compound represented by Chemical Formula IVb, wherein the side chain is selected from a (2R,3S)-phenylisoserine derivative, represented by Chemical Formula IIa and having protected groups introduced to 2-hydroxyl group and 3-amino group, and a mixture of the derivative with an isomer thereof, a (2S,3S)-phenylisoserine derivative, represented by Chemical Formula IIb;

2) deprotecting the mixture (IVa, IVb) obtained from step 1) at C-7 and/or C-10 position thereof to obtain a mixture of a compound represented by the following Chemical Formula VIa with a compound represented by the following Chemical Formula VIb;

3) separating the mixture (VIa, VIb) obtained from step 2) via chromatography to obtain each isomer compound;

4) deprotecting the side chain of each isomer compound obtained from step 3) at C-2 position thereof; and

5) carrying out a stereochemical reversion of one isomer compound having a (2S,3S)-side chain in the compounds obtained from step 4) into the other isomer compound having a (2R,3S)-side chain to obtain a taxane derivative represented by Chemical Formula I:

wherein R 1 , R 2 , R 3 , R 4 , R 1 ′ and Ph are the same as defined in claim 1 .

4. The method for preparing a taxane derivative according to claim 1 , wherein the side chain in step 1) is a racemic mixture of (2R,3S)-phenylisoserine derivative (IIa) with (2S,3S)-phenylisoserine derivative (IIb).

5. The method for preparing a taxane derivative according to claim 1 , wherein the chromatography is carried out in a normal phase chromatography mode using a column packed with silica gel having a particle diameter of 5-120 micrometers (μm).

6. The method for preparing a taxane derivative according to claim 1 , wherein the stereochemical reversion is carried out by reacting the mixture of isomers with triphenylphosphine and diethylazodicarboxylate or di-tert-butylazodicarboxylate in the presence of an organic solvent.

7. The method for preparing a taxane derivative according to claim 1 , wherein the taxane derivative is docetaxel or paclitaxel.

8. The method for preparing a taxane derivative according to claim 2 , wherein the side chain in step 1) is a racemic mixture of (2R,3S)-phenylisoserine derivative (IIa) with (2 S,3S)-phenylisoserine derivative (IIb).

9. The method for preparing a taxane derivative according to claim 2 , wherein the chromatography is carried out in a normal phase chromatography mode using a column packed with silica gel having a particle diameter of 5-120 micrometers (μm).

10. The method for preparing a taxane derivative according to claim 2 , wherein the stereochemical reversion is carried out by reacting the mixture of isomers with triphenylphosphine and diethylazodicarboxylate or di-tert-butylazodicarboxylate in the presence of an organic solvent.

11. The method for preparing a taxane derivative according to claim 2 , wherein the taxane derivative is docetaxel or paclitaxel.

12. The method for preparing a taxane derivative according to claim 3 , wherein the side chain in step 1) is a racemic mixture of (2R,3S)-phenylisoserine derivative (IIa) with (2S,3S)-phenylisoserine derivative (IIb).

13. The method for preparing a taxane derivative according to claim 3 , wherein the chromatography is carried out in a normal phase chromatography mode using a column packed with silica gel having a particle diameter of 5-120 micrometers (μm).

14. The method for preparing a taxane derivative according to claim 3 , wherein the stereochemical reversion is carried out by reacting the mixture of isomers with triphenylphosphine and diethylazodicarboxylate or di-tert-butylazodicarboxylate in the presence of an organic solvent.

15. The method for preparing a taxane derivative according to claim 3 , wherein the taxane derivative is docetaxel or paclitaxel.

Assignments (5)
CHANGE OF ADDRESS Recorded Nov 3, 2021
From: SAMYANG BIOPHARMACEUTICALS CORPORATION
To: SAMYANG BIOPHARMACEUTICALS CORPORATION
Reel/Frame 058013/0696 →
MERGER Recorded Nov 3, 2021
From: SAMYANG BIOPHARMACEUTICALS CORPORATION
To: SAMYANG HOLDINGS CORPORATION
Reel/Frame 058013/0766 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2013
From: SAMYANG GENEXBIO CORPORATION
To: SAMYANG BIOPHARMACEUTICALS CORPORATION
Reel/Frame 031721/0789 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2012
From: SAMYANG GENEX CORPORATION
To: SAMYANG GENEXBIO CORPORATION
Reel/Frame 028228/0097 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2011
From: PYO, SANG-HYUN; CHO, JIN SUK; KIM, MOON SUK; SONG, JAI YOUNG; CHOI, HO JOON
To: SAMYANG GENEX CORPORATION
Reel/Frame 027017/0385 →
Priority Claims (1)
KR 10-2009-0036055 · Apr 24, 2009 · national
Continuity (1)
Related Publication 20120035379A1 · Feb 9, 2012